Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Dr Camilla Zimmermann Dr Camilla Zimmermann highlights the need to change the stigma of palliative care.

Learn more

Funding world-class research

Icon - paper

Cancer affects all Canadians but together we can reduce the burden by investing in research and prevention efforts. Learn about the impact of our funded research.

Learn more